Large Cap
Medical Devices
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
1
Abbott
ABT
$181B
| $181B | $104.89 | 0.2% |
|
2
Medtronic
MDT
$121B
| $121B | $94.75 | 0.73% |
|
3
Stryker
SYK
$113B
| $113B | $294.66 | 0.49% |
|
4
Boston Scientific
BSX
$64.3B
| $64.3B | $44.39 | 0.57% |
|
5
Edwards Lifesciences
EW
$49.9B
| $49.9B | $86.60 | 1.7% |
|
6
DexCom
DXCM
$32.5B
| $32.5B | $86.04 | 1.9% |
|
7
GE HealthCare
GEHC
$31.4B
| $31.4B | $69.57 | 1.11% |
|
8
Philips
PHG
$25.2B
| $25.2B | $25.74 | 0.98% |
|
9
Steris
STE
$21.7B
| $21.7B | $222.66 | 0.74% |
|
10
Zimmer Biomet
ZBH
$18.1B
| $18.1B | $94.98 | 0.64% |
|
11
Penumbra
PEN
$12.6B
| $12.6B | $320.86 | 0.11% |
|
12
Smith & Nephew
SNN
$12.2B
| $12.2B | $29.06 | 0.1% |
|
13
Globus Medical
GMED
$10.3B
| $10.3B | $76.71 | 2.7% |
|
Large Cap Medical Devices Stocks at a Glance
Medical device companies develop surgical equipment, implants, pacemakers, imaging systems, and other therapeutic machines. Procedure volumes drive recurring demand, with regulatory approvals and surgeon adoption creating high switching costs and durable franchises around installed bases.
There are 13 large cap Medical Devices stocks — companies in the Medical Devices industry with a market cap between $10B and $200B — worth a combined $694B.
The largest by market cap are Abbott (ABT) at $181B, Medtronic (MDT) at $121B and Stryker (SYK) at $113B.
Among institutional investors, Edwards Lifesciences (EW) drew the most net new fund positions in Q2 2026: 164 funds opened new positions, taking total fund holders up 46 (3.6%) quarter-over-quarter.
- Combined market cap: $694B across 13 stocks.
- Large Cap: market cap between $10B and $200B.
- Largest constituent: Abbott (ABT), $181B market cap.
- Most net new fund positions in Q2 2026: Edwards Lifesciences (EW), +46 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.